High-purity GHK-Cu for laboratory research should meet or exceed a 99.0% RP-HPLC purity percentage. PX1 Research delivers reference-grade copper peptide reagents manufactured via USA synthesis, accompanied by lot-specific third-party COAs covering HPLC, MS identity verification, and endotoxin testing, shipped same-day Monday through Friday from California and Arizona facilities.
High-purity GHK-Cu for laboratory research should meet or exceed a 99.0% RP-HPLC purity percentage. PX1 Research delivers reference-grade copper peptide reagents manufactured via USA synthesis, accompanied by lot-specific third-party COAs covering HPLC, MS identity verification, and endotoxin testing, shipped same-day Monday through Friday from California and Arizona facilities.
When evaluating copper glycyl-L-histidyl-L-lysine (GHK-Cu) for biochemical and cell culture studies, establishing precise analytical standards is critical to ensure reproducible research outcomes. The target purity benchmark for GHK-Cu in laboratory applications is ≥99.0% as measured by reversed-phase high-performance liquid chromatography (RP-HPLC). Purity percentages below this threshold introduce uncharacterized peptide fragments, free copper ions, or synthesis reagents that interfere with cellular signaling assays.
Analytical verification must extend beyond simple HPLC peak area integration. A complete analysis includes matrix-assisted laser desorption/ionization mass spectrometry (MALDI-TOF MS) or electrospray ionization mass spectrometry (ESI-MS) to verify molecular mass (404.9 g/mol for the tripeptide-copper complex), net peptide content determination via nitrogen analysis or amino acid analysis (AAA), residual trifluoroacetic acid (TFA) quantification, and bacterial endotoxin testing (<0.01 EU/mg).
PX1 Research maintains rigorous analytical standards for all research compounds. Researchers can buy GHK-Cu 50mg vials with lot-specific certificates of analysis (COAs) validating exact purity percentage, chemical identity, and safety specs prior to dispatch.
GHK-Cu is a naturally occurring human plasma tripeptide (glycyl-L-histidyl-L-lysine) chelated with a copper(II) ion. In preclinical literature, GHK-Cu is widely researched for collagen and elastin synthesis, skin remodeling, wound closure, and reduced fibrotic scarring. It acts as a signaling complex that regulates gene expression across thousands of human genes, upregulating tissue regeneration pathways while downregulating pro-inflammatory cascades.
Because GHK-Cu modulates cellular activities at nanomolar concentrations, uncharacterized impurities in lower-grade preparations can significantly alter experimental outcomes. Unbound or poorly chelated copper ions cause oxidative stress in vitro via Fenton-like reactions, masking the true biological activity of the intact peptide complex. Similarly, truncated peptide impurities can act as competitive antagonists at cell surface receptors or alter enzymatic degradation kinetics in tissue cultures.
To ensure that observed cellular responses are attributable strictly to the chelated GHK-Cu complex, investigators must source reagents with proven chemical integrity. For comprehensive studies on tissue repair mechanisms, investigators frequently pair GHK-Cu with other extracellular matrix modifiers available in our full research peptide catalog.
In analytical chemistry, the acceptable purity percentage depends on the downstream research application. For cell culture, biochemical assays, and animal models, the baseline specification for GHK-Cu is ≥98.0%, with reference-grade material targeted at ≥99.0%. RP-HPLC analytical protocols evaluate purity by separating the primary peptide peak from synthesis side-products, such as missing-amino-acid sequences (deletion peptides), diastereomers, or oxidized fragments.
A chromatogram yielding 95% purity means that 5% of the total UV absorbance at 214 nm or 220 nm corresponds to unknown chemical entities. In delicate primary cell assays or quantitative gene expression studies, a 5% impurity profile represents a severe confounding variable. For instance, deletion sequences like HK-Cu or GH-Cu may bind non-specifically or yield false-negative biological signals.
Researchers reviewing the analytical specifications for GHK-Cu should verify that the reported purity percentage reflects the integrated peak area of the intact GHK-Cu complex relative to all detected impurities, rather than a crude total peptide calculation. To inspect verified chromatograms for current production batches, view our detailed GHK-Cu scientific documentation.
Reversed-phase high-performance liquid chromatography (RP-HPLC) is the gold standard method for quantifying peptide purity percentage. The process relies on a hydrophobic stationary phase (typically a C18 or C8 silica column) and a polar mobile phase consisting of water and acetonitrile modified with an ion-pairing agent, such as 0.1% trifluoroacetic acid (TFA) or formic acid.
During analysis, the GHK-Cu sample is dissolved in an aqueous buffer and injected onto the column under gradient elution conditions. As the organic solvent concentration increases, individual molecular species elute based on their unique hydrophobicities and charge states. Detection is typically performed using a UV/Vis spectrophotometer at 214 nm (peptide backbone absorption) and 280 nm or 600 nm (copper complex absorption).
The resulting chromatogram displays a dominant peak representing GHK-Cu alongside potential minor baseline peaks corresponding to impurities. The purity percentage is calculated using the following formula:
$$\text{Purity \%} = \left( \frac{\text{Area of GHK-Cu Peak}}{\text{Total Area of All Integrated Peaks}} \right) \times 100$$
At PX1 Research, every batch must exhibit a sharp, symmetrical single peak with a tailing factor near 1.0 and zero co-eluting artifact peaks to achieve an operational pass rating of ≥99.0% purity.
A common point of confusion in peptide research is the distinction between gross lyophilized weight and net peptide content. When a vial is labeled as containing 10 mg of GHK-Cu, this number represents the net weight of the active peptide compound, not the total mass of the powder in the vial.
Lyophilized peptide preparations naturally contain non-peptide components, including bound water (moisture content) and counterions (such as acetate or trifluoroacetate) resulting from the purification and salt-exchange processes. Consequently, the actual peptide content (net peptide content) in a standard lyophilized cake typically ranges between 75% and 85% of the total powder weight, with the remaining 15% to 25% composed of residual moisture and counterions.
To calculate exact molar concentrations for in vitro assays, researchers must account for the net peptide content provided on the certificate of analysis. For example, if a 10 mg vial has a net peptide content of 82.5%, the absolute mass of GHK-Cu present is 8.25 mg. Standardizing assays based on total powder mass without correcting for net peptide content introduces systematic errors in concentration-dependent studies. Investigators looking to stock verified reagents can order GHK-Cu vials directly with exact net peptide percentages detailed on each batch report.
During solid-phase peptide synthesis (SPPS) and subsequent preparative HPLC purification, trifluoroacetic acid (TFA) is utilized as a cleavage agent and mobile phase modifier. As a result, synthetic peptides are naturally isolated as TFA salts. However, residual TFA can exert cytotoxic effects in cell cultures and inhibit cell proliferation at elevated levels.
For sensitive cell culture and tissue remodeling experiments, residual TFA must be controlled or exchanged to an acetate salt form. High-quality research reagents should maintain residual TFA levels below 1.0% (preferably <0.5%). High levels of TFA alter the pH of unbuffered cell media, causing artifactual cell death that can be misattributed to the peptide itself.
Similarly, residual moisture must be controlled during the freeze-drying (lyophilization) process. Moisture levels exceeding 5% accelerate peptide hydrolysis and copper dissociation during long-term storage at -20°C or 4°C. PX1 Research enforces strict moisture control limits (typically <3.0% H2O via Karl Fischer titration) to preserve long-term chemical stability and prevent degradation over extended storage cycles.
While RP-HPLC establishes chemical purity percentage by separating molecular species, it cannot verify the precise identity or structural sequence of the molecule. Mass spectrometry (MS) provides structural confirmation by measuring the mass-to-charge ratio (m/z) of the ionized compound.
The theoretical monoisotopic mass of the uncomplexed GHK tripeptide is 340.18 g/mol. When chelated with copper(II) (Cu2+, atomic mass ~63.55 g/mol) and losing two protons to balance charge, the resulting neutral GHK-Cu complex has a theoretical molecular weight of approximately 404.9 g/mol. In electrospray ionization (ESI-MS) analysis, the primary signal corresponds to the protonated molecule [M+H]+ at m/z 405.9, or specific adducts depending on the ionization matrix.
Mass spectrometry confirms that the purified sample is indeed the correct copper-bound tripeptide complex rather than an uncomplexed GHK sequence or a mismatched synthetic fragment. A valid COA must feature an MS spectrum displaying a single, clear mass peak matching the theoretical molecular mass within ±0.5 Da, with no significant degradation peaks.
Bacterial endotoxins (lipopolysaccharides or LPS) are cell wall components of Gram-negative bacteria that trigger potent inflammatory responses in biological systems. In tissue culture and animal research evaluating collagen synthesis, skin remodeling, or wound closure, endotoxin contamination distorts baseline cytokine profiles and invalidates experimental data.
When endotoxins are present in GHK-Cu samples, cell lines upregulate pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α. This response directly counteracts the anti-inflammatory and tissue-protective properties being studied. To prevent experimental artifacts, reagent-grade GHK-Cu must undergo Limulus Amebocyte Lysate (LAL) testing or recombinant Factor C (rFC) assays.
The standard endotoxin threshold for high-purity research peptides at PX1 Research is <0.01 EU/mg, well below the threshold required to provoke inflammatory signaling in cellular models. This ensures that observed physiological effects stem solely from GHK-Cu activity rather than trace bacterial contaminants.
Reviewing a COA requires systematically checking analytical parameters against established laboratory thresholds. Below is a step-by-step guide to interpreting a third-party analytical report for GHK-Cu:
1. **Product Identifier and Lot/Batch Number**: Match the lot number printed on the physical vial label to the COA to ensure complete chain-of-custody verification.
2. **Appearance and Physical Description**: The lyophilized cake should appear as a uniform, light blue to deep blue powder. The distinct blue color confirms the presence of bound copper(II) ions. White or off-white powders indicate missing copper chelation or uncomplexed GHK.
3. **Identity Verification (MS)**: Confirm that the observed mass peak in the ESI-MS or MALDI-TOF spectrum matches the theoretical mass of 404.9 g/mol (or corresponding ionized m/z value).
4. **Purity Percentage (RP-HPLC)**: Check the integrated peak area table. The main GHK-Cu peak must account for ≥99.0% of the total integrated area at 214 nm.
5. **Net Peptide Content (AAA / Nitrogen Analysis)**: Verify the percentage of active peptide mass within the powder (typically 80–85%) to ensure accurate molar concentration calculations.
6. **Residual TFA and Water Content**: Confirm that TFA content is <1.0% and moisture is <5.0% (ideally <3.0%).
7. **Endotoxin Level (LAL Test)**: Ensure reported endotoxin levels fall below 0.01 EU/mg.
Evaluating suppliers requires a systematic comparison of analytical protocols, traceability, and quality controls. The criteria below illustrate the standards enforced by PX1 Research compared to typical commercial vendors:
• **RP-HPLC Purity Benchmark**: PX1 Research guarantees ≥99.0% purity per lot. Standard market vendors frequently supply material rated at 95.0–98.0% with uncharacterized side-peaks.
• **Mass Spectrometry Identity**: PX1 Research provides high-resolution ESI-MS spectra for every production batch. Standard vendors often omit MS spectrum data or rely on generic template reports.
• **Endotoxin Quantification**: PX1 Research conducts LAL endotoxin testing on every lot (<0.01 EU/mg limit). Standard vendors rarely perform routine endotoxin screening.
• **Net Peptide Content & TFA Data**: PX1 Research explicitly details net peptide percentage and TFA content on each COA. Standard vendors omit counterion and moisture data, forcing researchers to estimate net mass.
• **Synthesis Sourcing & Facility Standards**: PX1 Research utilizes domestic USA synthesis under strict ISO 9001 quality management systems. Standard vendors rely on unverified offshore re-packagers.
• **Lot Traceability & Storage**: PX1 Research maintains full batch retention and cold-chain storage at CA and AZ facilities. Standard vendors store stock at ambient room temperatures without lot tracking.
Researchers requiring fully documented, high-purity compounds for comparative tissue studies can explore related matrix repair agents, including BPC-157 5mg vials and TB-500 research reagents.
Navigating the research chemical market requires vigilance against low-quality or mislabeled materials. When evaluating vendor documentation for GHK-Cu, watch for these common red flags:
• **White or Off-White Lyophilized Powder**: GHK-Cu must exhibit a characteristically distinct blue shade due to the d-d orbital electron transitions of the copper(II) coordination complex. A white powder indicates uncomplexed GHK peptide lacking copper.
• **Generic or Static COAs**: Vendors presenting identical COAs across multiple lots over several months are not conducting true lot-specific testing. Every batch requires independent testing.
• **HPLC Integration Manipulation**: Look at the chromatogram baseline. Unscrupulous suppliers may cut off integration before baseline artifacts appear or crop the chromatogram to artificially inflate reported purity percentages.
• **Missing Mass Spectrum**: A vendor offering HPLC data without MS documentation cannot verify that the dominant peak is actual GHK-Cu rather than an isomeric or related impurity.
• **Unusually Low Prices without Technical Specifications**: Products priced significantly below synthesis costs typically reflect raw, unpurified crude peptides containing heavy metals, unreacted reagents, or high endotoxin levels.
When purchasing GHK-Cu for laboratory studies, PX1 Research provides reference-grade reagents with complete analytical documentation and chain-of-custody tracking. Every order includes verified net peptide values, lot-matched COAs, and rapid domestic fulfillment.
• **Vial Formats**: GHK-Cu is supplied in vacuum-sealed, rubber-stoppered glass vials containing 50 mg or 100 mg of lyophilized cake.
• **Fulfillment Cutoffs**: Orders placed before 12:00 PM PST (Monday through Friday) dispatch same-day from our primary California or Arizona distribution hubs.
• **Shipping & Handling**: All packages ship via tracked domestic carrier services using cold-pack temperature preservation when required.
• **COA Access**: Full third-party HPLC, MS, and endotoxin reports are accessible online by scanning the QR code on the physical vial label or entering the batch number on our portal.
To review current inventory, volume pricing, and lot documentation, visit the official GHK-Cu product page or consult our technical support team for custom assay requirements.
What is the standard purity percentage required for GHK-Cu research?
GHK-Cu used in laboratory research should maintain an RP-HPLC purity percentage of at least 98.0%, with reference-grade studies targeting ≥99.0%. High purity prevents baseline interference from synthetic deletion sequences, uncomplexed peptides, or unbound copper ions in cell culture and animal tissue models.
Why is high purity GHK-Cu blue in color?
GHK-Cu exhibits a distinct blue color due to the chelation of the copper(II) ion (Cu2+) by the glycyl-L-histidyl-L-lysine tripeptide. The coordination complex creates specific light absorption in the visible spectrum. A white or colorless powder indicates missing copper chelation or pure GHK without copper.
Do you provide a lot-specific COA for GHK-Cu?
Yes, PX1 Research provides a lot-specific Certificate of Analysis for every batch of GHK-Cu. Each COA includes third-party RP-HPLC chromatograms, electrospray ionization mass spectrometry (ESI-MS) spectra, net peptide content analysis, residual TFA quantification, and LAL endotoxin test results.
What is the difference between gross weight and net peptide content?
Gross weight refers to the total mass of the lyophilized powder in the vial, which includes the peptide, counterions (such as TFA or acetate), and residual moisture. Net peptide content reflects the exact percentage of active GHK-Cu peptide mass, usually 80–85% of total powder weight.
What are the acceptable endotoxin limits for research-grade GHK-Cu?
Acceptable endotoxin limits for cellular and animal studies should be less than 0.01 EU/mg. Low endotoxin levels prevent non-specific inflammatory activation via Toll-like receptors in primary cell cultures and tissue regeneration models.
How fast does PX1 Research ship GHK-Cu orders?
Orders placed before 12:00 PM PST, Monday through Friday, ship same-day from PX1 Research facilities in California and Arizona. Fast domestic shipping ensures minimal transit times and maintains compound integrity.
Is GHK-Cu legal to purchase for research in the United States?
Yes, GHK-Cu is legal to purchase in the United States as a laboratory research chemical. It is intended strictly for in vitro and preclinical research applications and is not approved for human consumption, therapeutic use, or clinical administration.
How should GHK-Cu be stored upon receipt in the laboratory?
Lyophilized GHK-Cu powder should be stored at -20°C or -80°C for long-term stability, protected from light and moisture. Reconstituted solutions in sterile, buffered aqueous media should be aliquoted and stored at -20°C to prevent freeze-thaw degradation.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.